Published in Blood Weekly, June 23rd, 2005
"Growth hormone-releasing hormone (GHRH) is a potentially appealing strategy to simultaneously improve fat distribution and increase bone turnover in HIV-infected patients.
"We investigated the effects of GHRH (1 mg subcutaneously twice a day over 12 weeks) in 31 HIV-infected men with abdominal fat accumulation (age 46±1 year, body mass index 26.2±0.6 kg/m2) in a randomized, double-blind, placebo-controlled study," researchers in the United States report.
"We previously reported...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.